OPC

DRUG3 trials

Sponsors

Bial - Portela C S.A., Medical University of South Carolina

Conditions

Breast CancerParkinson's Disease (PD)Prostate Cancer

Phase 1

An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites

CompletedNCT02169427

Bial - Portela C S.A.Parkinson's Disease (PD)

Start: 2011-03-31End: 2011-07-31Updated: 2015-08-21

AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy

TerminatedNCT03092635

Medical University of South CarolinaBreast Cancer

Start: 2017-06-06End: 2022-04-22Updated: 2025-01-06

Phase 2

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

TerminatedNCT02946996

Medical University of South CarolinaProstate Cancer

Start: 2016-12-28End: 2024-08-19Updated: 2026-03-05

Related Papers

Abstract C025: Dietary-AGE ingestion during puberty modifies the breast microenvironment to alter mammary gland development: Linking lifestyle with cancer disparity

Cancer Epidemiology Biomarkers & Prevention2020-06-01